vimarsana.com

Latest Breaking News On - Second closing - Page 1 : vimarsana.com

Bionomics : SECURITIES PURCHASE AGREEMENT - Form 6-K

YANDEX N : UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION - Form 6-K

Allotment and issue of Second Tranche Shares | Company Announcement

Form 10-K Xtant Medical Holdings, For: Dec 31

Form 10-K Xtant Medical Holdings, For: Dec 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Molecular Templates, Inc Reports Fourth Quarter 2023 Financial Results and Business Update

AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (“ETBs”), to create novel therapies with potent differentiated mechanisms of action for cancer, today reported financial results for the fourth quarter and full year ended December 31, 2023. Company Highlights Durable s

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.